A phase 2, open-label study of single-dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy
收藏Mendeley Data2021-03-08 更新2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/ctdyb5zvs5
下载链接
链接失效反馈官方服务：
资源简介：
Author video for the article: Paller AS, Siegfried EC, et al. A phase 2, open-label study of single-dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy. J Eur Acad Dermatol Venereol. 2021;35(2):464-475.
创建时间：
2021-03-08
